Amed Co., Ltd. (7575.TWO)

TWD 41.65

(-2.0%)

EBITDA Summary of Amed Co., Ltd.

  • Amed Co., Ltd.'s latest annual EBITDA in 2023 was 157.32 Million TWD , up 6.42% from previous year.
  • Amed Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 74.8 Million TWD , down -17.83% from previous quarter.
  • Amed Co., Ltd. reported an annual EBITDA of 144.96 Million TWD in 2022, up 39.01% from previous year.
  • Amed Co., Ltd. reported an annual EBITDA of 106.2 Million TWD in 2021, up 21.56% from previous year.
  • Amed Co., Ltd. reported a quarterly EBITDA of 66.28 Million TWD for 2023 Q2, down -21.38% from previous quarter.
  • Amed Co., Ltd. reported a quarterly EBITDA of N/A for 2023 FY, up 6.42% from previous quarter.

Annual EBITDA Chart of Amed Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Amed Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 157.32 Million TWD 6.42%
2022 144.96 Million TWD 39.01%
2021 106.2 Million TWD 21.56%
2020 87.42 Million TWD 0.0%
2019 69.34 Million TWD 0.0%

Peer EBITDA Comparison of Amed Co., Ltd.

Name EBITDA EBITDA Difference
St.Shine Optical Co.,Ltd. 1.01 Billion TWD 84.439%
Bioteque Corporation 736.13 Million TWD 78.628%
Chi Sheng Pharma & Biotech Co., Ltd 117.55 Million TWD -33.835%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD -105.352%
BenQ Medical Technology Corporation 532.15 Million TWD 70.436%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD 76.651%
Unicon Optical Co., Ltd. 377.24 Million TWD 58.297%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 84.952%
Medeon Biodesign, Inc. -1.14 Billion TWD 113.777%
Concord Medical Co., Ltd. 137.47 Million TWD -14.441%
Crystalvue Medical Corporation 149.73 Million TWD -5.072%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD -36.237%
ICARES Medicus, Inc. 165.54 Million TWD 4.963%
Lagis Enterprise Co., Ltd. 112.36 Million TWD -40.015%